Howard Marks (Oaktree Capital) disclosed sold in 88162GAB9

Howard Marks (Oaktree Capital) filed a 13F change in 88162GAB9 (88162GAB9) on 2026-05-20, covering period end 2026-03-31.

Action

Sold

Capital

$16,626,023 reported value

Why it matters

This signal is anchored to the SEC filing date while retaining the underlying 13F period end.

SaleNHC

SHELLY TIMOTHY J. disclosed a sale transaction in NATIONAL HEALTHCARE CORP (NHC) on 2026-05-20.

EVNIN LUKE disclosed a sale transaction in Werewolf Therapeutics Inc (HOWL) on 2026-05-20.